yes what about the competing the other products in the market and do not forget that this is the biotech market not the butcher market; these products need more reliability n publicity not the taste... our product already had great features, but it need publicity and need more surgeons use it and it takes time...could not be done just like that if there are other products in the market. The positive sides are that our product has more success that the other products but it takes time to get used by the centers...
Ann: Half Year Report, page-18
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.74 |
Change
-0.170(0.95%) |
Mkt cap ! $347.9M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.73 | $39.85K | 2.224K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 611 | $17.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.90 | 85 | 3 |
View Market Depth
| Last trade - 13.11pm 16/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |